Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.
Identification of CD8(+) T cell epitopes that can induce T cells to kill tumor cells is a fundamental step for development of a peptide cancer vaccine. POTE protein is a newly identified cancer antigen that was found to be expressed in a wide variety of human cancers, including prostate, colon, lung...
Main Authors: | Yi-Hsiang Huang, Masaki Terabe, C David Pendleton, Deborah Stewart Khursigara, Tapan K Bera, Ira Pastan, Jay A Berzofsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3672105?pdf=render |
Similar Items
-
HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
by: Tsukahara Tomohide, et al.
Published: (2009-06-01) -
HLA-A*0201-restricted CTL epitopes in Rv0350 and Rv0351 of latent Mycobacterium tuberculosis
by: Y. Sun, et al.
Published: (2014-04-01) -
Identification of Two Novel HLA-A∗0201-Restricted CTL Epitopes Derived from MAGE-A4
by: Zheng-Cai Jia, et al.
Published: (2010-01-01) -
Autophagy creates a CTL epitope that mimics tumor-associated antigens.
by: Ayako Demachi-Okamura, et al.
Published: (2012-01-01) -
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
by: Christian B Willberg, et al.
Published: (2010-04-01)